Citation Impact
Citing Papers
Effects of 1-methyltryptophan stereoisomers on IDO2 enzyme activity and IDO2-mediated arrest of human T cell proliferation
2012
The Role of Macrophages in Acute and Chronic Wound Healing and Interventions to Promote Pro-wound Healing Phenotypes
2018 Standout
Monocyte recruitment during infection and inflammation
2011 Standout
From Monocytes to M1/M2 Macrophages: Phenotypical vs. Functional Differentiation
2014 Standout
1,2,3-Triazoles as inhibitors of indoleamine 2,3-dioxygenase 2 (IDO2)
2016
Cancer Immunotherapy by Targeting IDO1/TDO and Their Downstream Effectors
2015
CRISPR-Cas9 screens identify regulators of antibody–drug conjugate toxicity
2019 StandoutNobel
Lipid nanoparticles (LNP) induce activation and maturation of antigen presenting cells in young and aged individuals
2023 StandoutNobel
Human CD14dim Monocytes Patrol and Sense Nucleic Acids and Viruses via TLR7 and TLR8 Receptors
2010
Inflammation and wound healing: the role of the macrophage
2011 Standout
Drawing lessons from the clinical development of antibody-drug conjugates
2018
Rapid online buffer exchange for screening of proteins, protein complexes and cell lysates by native mass spectrometry
2020 StandoutNobel
Fate Mapping Reveals Origins and Dynamics of Monocytes and Tissue Macrophages under Homeostasis
2012 Standout
CD54 is a surrogate marker of antigen presenting cell activation
2008
Kynurenines in the CNS: recent advances and new questions
2012
Strategies and challenges for the next generation of antibody–drug conjugates
2017 Standout
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
2010 Standout
Understanding the Intersections between Metabolism and Cancer Biology
2017 Standout
Coinhibitory Receptor Expression and Immune Checkpoint Blockade: Maintaining a Balance in CD8+ T Cell Responses to Chronic Viral Infections and Cancer
2017 StandoutNobel
Serotonin, tryptophan metabolism and the brain-gut-microbiome axis
2014 Standout
Protective and pathogenic functions of macrophage subsets
2011 Standout
Establishment of a human indoleamine 2, 3-dioxygenase 2 (hIDO2) bioassay system and discovery of tryptanthrin derivatives as potent hIDO2 inhibitors
2016
Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond
2019 Standout
Important Hydrogen Bond Networks in Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitor Design Revealed by Crystal Structures of Imidazoleisoindole Derivatives with IDO1
2015
Challenges in the Discovery of Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors
2015
Cancer Immunotherapy: Selected Targets and Small‐Molecule Modulators
2016
Trop-2 is a novel target for solid cancer therapy with sacituzumab govitecan (IMMU-132), an antibody-drug conjugate (ADC)*
2015
Efficient tryptophan‐catabolizing activity is consistently conserved through evolution of TDO enzymes, but not IDO enzymes
2015
IDO2 Is a Critical Mediator of Autoantibody Production and Inflammatory Pathogenesis in a Mouse Model of Autoimmune Arthritis
2014
Tryptophan Catabolism in Cancer: Beyond IDO and Tryptophan Depletion
2012
T cell exclusion, immune privilege, and the tumor microenvironment
2015 StandoutScience
Quantitative Determination of Protein–Ligand Affinity by Size Exclusion Chromatography Directly Coupled to High-Resolution Native Mass Spectrometry
2018
Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4
2013 StandoutNobel
Works of Lara Stepan being referenced
Specific stimulation of MHC-transgenic mouse T-cell hybridomas with xenogeneic APC
2003
Purification and kinetic characterization of human indoleamine 2,3-dioxygenases 1 and 2 (IDO1 and IDO2) and discovery of selective IDO1 inhibitors
2011
Expression of Trop2 Cell Surface Glycoprotein in Normal and Tumor Tissues
2011